Clinical outcomes of immune checkpoint blockades and the underlying immune escape mechanisms in squamous and adenocarcinoma NSCLC

Immune checkpoint blockades (ICBs) have changed the standard of care of squamous and adenocarcinoma non‐small cell lung cancer (NSCLC). Whereas detailed researches regarding ICBs in the two major histological subtypes are rare. In order to uncover the clinical efficacy differences between squamous a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yaru, Zhai, Xiaoyang, Yan, Weiwei, Zhu, Hui, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826453/
https://www.ncbi.nlm.nih.gov/pubmed/33230935
http://dx.doi.org/10.1002/cam4.3590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826453/
https://www.ncbi.nlm.nih.gov/pubmed/33230935
http://dx.doi.org/10.1002/cam4.3590

Ejemplares similares